Navigation Links
University of Muenster Bridges 1st Patient to Transplant with SynCardia's Total Artificial Heart

TUCSON, Ariz., Aug. 17, 2011 /PRNewswire/ -- SynCardia Systems, Inc. (, manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University of Muenster in Germany has successfully bridged its first patient to transplant with the Total Artificial Heart after 89 days of support.


On Jan. 14, 60-year-old Jan Detert was admitted to University of Muenster as an emergency heart attack case (acute myocardial infarction). He was also suffering from a ventricular septal defect, a hole between the left and right ventricles of the heart.

Mr. Detert underwent emergency surgery that included aortocoronary bypass to create a new path to his aorta around a blocked artery, in addition to closing the hole between his heart ventricles using a patch. Two weeks after Mr. Detert's initial recovery from this surgery, he deteriorated when the ventricular septal defect recurred because his tissue had been severely weakened by the heart attack.

"SynCardia's Total Artificial Heart was our only option to save this patient's life," said Prof. Dr. Hans Scheld, Director of the Department of Thoracic and Cardiovascular Surgery. "This case demonstrates that the Total Artificial Heart is capable of bridging a patient with extended myocardial infarction, including ventricular septal defect, to successful heart transplantation."

On Jan. 30, Prof. Dr. T.D.T. Tjan and Prof. Dr. Andreas Hoffmeier implanted Mr. Detert with SynCardia's Total Artificial Heart. His condition stabilized and three months later, on April 29, he became the hospital's first patient to be successfully bridged to transplant with the Total Artificial Heart. Mr. Detert was discharged from the hospital with his new donor heart in June.

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the Total is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. More than 950 implants account for more than 230 patient years of life.

Similar to a heart transplant, SynCardia's Total Artificial Heart replaces both failing heart ventricles and the four heart valves. It is the only device that eliminates the symptoms and source of end-stage biventricular failure. The Total Artificial Heart provides immediate, safe blood flow of up to 9.5 liters per minute through both ventricles. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

In March 2011, Fast Company magazine ranked SynCardia #20 among the World's 50 Most Innovative Companies "for giving mobility to artificial heart recipients." Also in March, the longest running health and wellness series on public television, "Healthy Body, Healthy Mind," produced a 30-minute program featuring SynCardia's Total Artificial Heart. View here

For additional information, please visit:

or follow SynCardia on Twitter – @SynCardia_News

SOURCE SynCardia Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier and the National University of Singapore Announce Winners of 24-Hour Hackathon
2. The Human Brain is Sensitive to Light, Breakthrough Findings From Valkee and the University of Oulu
3. CEM President and CEO Delivers Commencement Address at the University of Texas at Austin Chemistry and Biochemistry Department Graduation
4. Computerized system to prevent SIDS developed by Ben-Gurion University students
5. University of Dayton Study Overturns 250-Year-Old Belief About Effects of Age, Repeated Injury on Tissue Regeneration
6. Waters Recognizes Albert J. Fornace Laboratory at Georgetown University Medical Center as a Center of Innovation
7. Lehigh University leads Department of Defense MURI grant for atomic-scale interphase research
8. UCB to Launch Research Alliance With Harvard University
9. Northern Illinois University scientists find simple way to produce graphene
10. The Pittsburgh Life Sciences Greenhouse Announces Innovative Partnership With University of Pittsburgh Biomedical Engineering Society
11. University of Houston develops method for creating single-crystal arrays of graphene
Post Your Comments:
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):